Aegle Therapeutics is a clinical-stage regenerative medicine company that develops novel therapeutics.
Aegle Therapeutics has raised $456K in total funding. The most recent round was Debt Financing. The last funding was announced in March 2026.
Aegle Therapeutics's investors include DeepWork Capital, Ocean Azul Partners, DEFTA Partners, New World Angels, Tellus BioVentures.
Aegle Therapeutics is headquartered in Miami, United States.
Aegle Therapeutics is a clinical-stage regenerative medicine company that develops novel therapeutics.
Aegle Therapeutics is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aegle Therapeutics — Funding & Investors." VCBacked, March 3, 2026, https://www.vcbacked.co/company/aegle-therapeutics. Accessed September 30, 2026.
VCBacked. (2026). Aegle Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/aegle-therapeutics
{{cite web |title=Aegle Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aegle-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated